Pretax income is the income that a company earns before paying income taxes. Neogen's pretax income for the
three
months ended in Feb. 2024 was $-5.8 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.3 Mil.
Neogen's pretax margin was -2.54%.
During the past 13 years, Neogen's highest Pretax Margin was 18.61%. The lowest was -2.68%. And the median was 17.34%.
Neogen Pre-Tax Income Historical Data
The historical data trend for Neogen's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Neogen's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neogen's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Neogen's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Neogen's Pre-Tax Income falls into.
Neogen Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Neogen's Pretax Income for the fiscal year that ended in May. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neogen (NAS:NEOG) Pre-Tax Income Explanation
Neogen's Pretax Margin for the quarter that ended in Feb. 2024 is calculated as
During the past 13 years, Neogen's highest Pretax Margin was 18.61%. The lowest was -2.68%. And the median was 17.34%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neogen Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Neogen's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NEOG has been successfully added to your 